Effect of Cyclophosphamide Pulse Therapy in a Patient with Intractable Lupus Nephritis

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

A 32-year-old female was suffering from intractable lupus nephritis (LN). Prednisolone at 30 mg per day had been prescribed for two months because of massive proteinuria and edema. After that, anasarca and orthopnea were induced, and hypoproteinemia, hypercholesteremia, and Anticardiolipin antibody were observed. Prednisolone at a dose of 60 mg per day was necessary. However, there was no improvement of the nephrotic state and renal pathological changes shown as diffuse proliferative lupus nephritis were followed by moderate crescent formation as determined by serial needle biopsy. Cyclophosphamide (CYP) pulse therapy was started and marked improvement of LN was obtained clinically and serologically without significant adverse effects. © 1990, The Japanese Society of Internal Medicine. All rights reserved.

Cite

CITATION STYLE

APA

Shibasaki, T., Matsumoto, H., Ohno, I., Matsuda, H., Kanai, T., Ishimoto, F., & Sakai, O. (1990). Effect of Cyclophosphamide Pulse Therapy in a Patient with Intractable Lupus Nephritis. Japanese Journal of Medicine, 29(4), 414–416. https://doi.org/10.2169/internalmedicine1962.29.414

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free